The Paradox of Progress: Does Biosimilar Competition Truly Reduce Patient Out-of-Pocket Costs for Biologic Drugs?
Biologic drugs have ushered in a new era of therapeutic possibilities, revolutionizing the treatment landscape for a myriad of chronic […]
